Also trades as: BH-R.BK (SET) · $vol 26M · BH.BK (SET) · $vol 25M · BUGDF (OTC) · $vol 0M · BZ7A.F (FSX) · $vol 0M
BUHPF OTC
Bumrungrad Hospital Public Company Limited
1W: +0.0%
1M: +0.0%
3M: +10.1%
YTD: +6.2%
1Y: +23.7%
3Y: -2.8%
5Y: +66.2%
$6.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$25.1B
-2.3% ▼
5Y CAGR: +15.2%
Gross Profit
$12.7B
-4.0% ▼
5Y CAGR: +22.0%
Operating Income
$8.8B
-4.3% ▼
5Y CAGR: +44.9%
Net Income
$7.5B
-3.5% ▼
5Y CAGR: +44.2%
EPS (Diluted)
$8.51
-5.0% ▼
5Y CAGR: +43.7%
EBITDA
$9.8B
-6.5% ▼
5Y CAGR: +29.3%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $12.5B | $20.7B | $25.4B | $25.7B | $25.1B |
| YoY Growth | +0.8% | +66.3% | +22.5% | +1.3% | -2.3% |
| Cost of Revenue | $7.7B | $11.1B | $12.9B | $12.5B | $12.4B |
| Gross Profit | $4.7B | $9.6B | $12.5B | $13.2B | $12.7B |
| Gross Margin | 38.0% | 46.4% | 49.2% | 51.4% | 50.5% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3.3B | $3.8B | $4.2B | $4.2B | $3.9B |
| Operating Expenses | $3.2B | $3.6B | $4.0B | $4.0B | $3.9B |
| Operating Income | $1.5B | $6.0B | $8.5B | $9.2B | $8.8B |
| Operating Margin | 12.2% | 29.0% | 33.5% | 35.6% | 34.9% |
| Interest Expense | $120M | $4M | $2M | $8M | $7M |
| Income Before Tax | $1.5B | $6.0B | $8.6B | $9.4B | $9.3B |
| Tax Expense | $216M | $1.1B | $1.6B | $1.6B | $1.7B |
| Net Income | $1.2B | $4.9B | $7.0B | $7.8B | $7.5B |
| Net Margin | 9.8% | 23.8% | 27.6% | 30.2% | 29.9% |
| EPS (Diluted) | $1.40 | $5.69 | $8.08 | $8.96 | $8.51 |
| EBITDA | $2.8B | $7.2B | $9.7B | $10.5B | $9.8B |
| Shares Outstanding | 867M | 867M | 867M | 867M | 867M |